METHYL 6-NITRO-1H-INDAZOLE-4-CARBOXYLATE, 95%, 250mg

(1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl succinimidyl carbonate, ?97.0%, 50mg

2-(4-morpholinyl)-8-quinolinol, 95.0%, 250mg

Fatty acid methyl ester mixture, ROTICHROM® ME 39, 100 mg, plastic packaging.

tert-Butyl (2-(bis(3-aminopropyl)amino)ethyl)carbamate, 97%, 2.5g

4-(3,4-Diethoxy-benzyloxy)-benzaldehyde, 250mg

GC capillary column ROTI®Cap-1701, 25 m, 0.20 mm, 0.20 µm, 1 Piece(s)

1-Methyl-4-(6-nitropyridin-3-yl)piperazine, 95.0%, 250mg

Methyl 8-quinolinecarboxylate, 98%, 5g

4-Acetoxybenzoic Acid>98.0%(GC)(T)500g

(S)-3-((tert-Butoxycarbonyl)amino)-4-(2,4-difluorophenyl)butanoic acid, 98%, 1g

Ethyl 1-(4-aminopyridin-2-yl)-1H-pyrazole-4-carboxylate, 95.0%, 100mg

6-(4-Fluorophenoxy)pyridine-3-boronic acid, 98%, 1g